about
In vitro inhibition of transthyretin aggregate-induced cytotoxicity by full and peptide derived forms of the soluble receptor for advanced glycation end products (RAGE)Deposition of transthyretin in early stages of familial amyloidotic polyneuropathy: evidence for toxicity of nonfibrillar aggregatesSubstrate specificity of transthyretin: identification of natural substrates in the nervous system.Peripheral nervous system plasmalogens regulate Schwann cell differentiation and myelination.Central role of RAGE-dependent neointimal expansion in arterial restenosis.Early axonal loss accompanied by impaired endocytosis, abnormal axonal transport, and decreased microtubule stability occur in the model of Krabbe's disease.The role of brain-derived neurotrophic factor (BDNF) in the development of neurogenic detrusor overactivity (NDO).Neurodegeneration in familial amyloid polyneuropathy: from pathology to molecular signaling.Deciphering cryptic proteases.The Actin-Binding Protein α-Adducin Is Required for Maintaining Axon Diameter.Transthyretin: more than meets the eye.Chapter 17: Transthyretin: an enhancer of nerve regeneration.Neuropeptide Y and osteoblast differentiation--the balance between the neuro-osteogenic network and local control.Regenerative medicine for the treatment of spinal cord injury: more than just promises?Advances and pitfalls of cell therapy in metabolic leukodystrophies.Cell intrinsic control of axon regeneration.Transthyretin neuroprotection in Alzheimer's disease is dependent on proteolysis.Fibrin functionalization with synthetic adhesive ligands interacting with α6β1 integrin receptor enhance neurite outgrowth of embryonic stem cell-derived neural stem/progenitors.The Dyslexia-susceptibility Protein KIAA0319 Inhibits Axon Growth Through Smad2 Signaling.The cytoskeleton as a novel therapeutic target for old neurodegenerative disorders.Axonal pathology in Krabbe's disease: The cytoskeleton as an emerging therapeutic target.Systemic delivery of bone marrow-derived mesenchymal stromal cells diminishes neuropathology in a mouse model of Krabbe's disease.Myelin Lipids Inhibit Axon Regeneration Following Spinal Cord Injury: a Novel Perspective for Therapy.Neuropeptide Y expression and function during osteoblast differentiation--insights from transthyretin knockout mice.Transthyretin, a new cryptic protease.Primary bone marrow mesenchymal stromal cells rescue the axonal phenotype of Twitcher mice.Transthyretin knockout mice display decreased susceptibility to AMPA-induced neurodegeneration.Neurophysiological, behavioral and morphological abnormalities in the Fabry knockout mice.Increase in ghrelin levels after weight loss in obese Zucker rats is prevented by gastric banding.The neuronal and actin commitment: Why do neurons need rings?Deposition and passage of transthyretin through the blood-nerve barrier in recipients of familial amyloid polyneuropathy livers.Axonal elongation and dendritic branching is enhanced by adenosine A2A receptors activation in cerebral cortical neurons.Transthyretin knockouts are a new mouse model for increased neuropeptide Y.Transthyretin is not expressed by dorsal root ganglia cells.Transthyretin internalization by sensory neurons is megalin mediated and necessary for its neuritogenic activity.Inhibitory Injury Signaling Represses Axon Regeneration After Dorsal Root Injury.ApoA-I cleaved by transthyretin has reduced ability to promote cholesterol efflux and increased amyloidogenicity.Up-regulation of the extracellular matrix remodeling genes, biglycan, neutrophil gelatinase-associated lipocalin, and matrix metalloproteinase-9 in familial amyloid polyneuropathy.The intriguing nature of dorsal root ganglion neurons: Linking structure with polarity and functionNeuronal Intrinsic Regenerative Capacity: The Impact of Microtubule Organization and Axonal Transport
P50
Q24337632-8B79E2D3-6AF7-48FD-ACDA-07F752EBF068Q24685634-DF3C1DEF-99EB-4548-BD31-6ECFFC491B32Q33399237-9994FBD0-847F-4B1B-84AC-27FD56E55683Q33685924-82B1EB1D-0772-4C94-AABA-C6CCC1509406Q34890522-CCCB3F06-1F0B-4963-800E-955524AD6D8CQ35015599-60E2ED9E-12A2-45F3-832A-26B7200E8899Q35044823-DA883D77-442D-4C94-ADAF-8193130547D0Q35646136-04023FFD-90A6-473D-8F87-32E4735A007AQ36068347-3BA5FA86-47BF-44A3-8899-4DD3F3FB5BDAQ36818370-7B01890F-56DA-4F64-8509-CD88087AD8B8Q37576502-5DAE4F0D-F5BA-434C-90FA-61B168A2F2B4Q37580190-A21B41FB-59BB-4E71-8FD2-E3310178F08CQ37777428-57212445-68FC-4084-8CB0-8F0535C25329Q38026986-8692D7F1-9671-4DA5-8A0C-B41CFAF8EF97Q38046023-99F5DA99-8F7D-4800-8C91-875752E013FDQ38188439-A375715C-EBFC-41C0-A6BD-D7AD69552466Q38638835-9793A9F6-97C9-4B0F-8BCD-ED71C87B5DBBQ38685448-5582372E-D879-4BF6-843B-937A8B368F23Q38711030-4497B1A1-BD95-42F2-AC7E-5B179AFA1F15Q38812452-3B73E7A6-C855-4032-BDB3-B3DD2500996DQ38957250-90F11EE2-4AD2-4A05-A3C8-ABF0D15C0E7CQ39478232-47DA072E-0866-4C50-95F4-FD8665A24CB7Q41595186-D0C8864A-6EFE-41FE-AD38-7B9C3207546EQ42831731-D7EE9921-C35F-4707-A1D4-6C18111384E5Q44807426-6810B749-C9FB-4FDA-9986-99540B226162Q45893113-EADA593A-5EEE-4BA6-8CDE-59BED72F0F27Q45930762-961886B8-3B0F-4AB3-A2FD-A4C0B0997BEAQ46320703-7D14EBD7-5E56-478B-9DE4-E2046D924F04Q46873816-0D6ADAFC-5BDF-4292-8229-B7F5650338E7Q47594962-B3307621-3BF6-43AB-A8DA-C25A10F0D695Q47662219-9E11E146-9E60-4B6A-9927-9A91B211E913Q48132428-BE0E2023-22D6-4B0C-9ADF-B68CD979ABACQ48709471-BFAB811B-3035-4465-B40B-0CD1629ABD43Q48893132-F129CF90-8671-4B15-843D-7D566D9CFD25Q51772974-591B234C-1B02-476C-8589-FADAC97E937AQ53370006-97AC70F0-B1A5-43CA-93A4-908720412AFFQ53535072-AE0C535F-7C96-4FAF-BC31-7E7CA09426ABQ53880179-D00FC1B3-3DDB-43CE-9003-A05D9F29C02BQ58153839-B66B4AAD-6225-46D1-8AC4-B176A0C35B1FQ58153852-54B49AAE-6B2C-4E6F-B2AF-5F2E44EDC721
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
ricercatrice
@it
հետազոտող
@hy
name
Mónica M. Sousa
@ast
Mónica M. Sousa
@en
Mónica M. Sousa
@es
Mónica M. Sousa
@sl
type
label
Mónica M. Sousa
@ast
Mónica M. Sousa
@en
Mónica M. Sousa
@es
Mónica M. Sousa
@sl
prefLabel
Mónica M. Sousa
@ast
Mónica M. Sousa
@en
Mónica M. Sousa
@es
Mónica M. Sousa
@sl
P214
P1053
K-4367-2013
P106
P1153
7103201347
P21
P213
0000 0000 6990 6354
P214
P2798
P31
P3829
P496
0000-0002-4524-2260